Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, Mai J, Shen H, Hu DZ, Adoro S, Hu B, Song M, Tan C, Landis MD, Ferrari M, Shin SJ, Brown M, Chang JC, Liu XS, Glimcher LH. Chen X, et al. Among authors: hatziapostolou m. Nature. 2014 Apr 3;508(7494):103-107. doi: 10.1038/nature13119. Epub 2014 Mar 23. Nature. 2014. PMID: 24670641 Free PMC article.
Epigenetic aberrations during oncogenesis.
Hatziapostolou M, Iliopoulos D. Hatziapostolou M, et al. Cell Mol Life Sci. 2011 May;68(10):1681-702. doi: 10.1007/s00018-010-0624-z. Epub 2011 Jan 20. Cell Mol Life Sci. 2011. PMID: 21249513 Review.
Therapeutically targeting microRNAs in liver cancer.
Drakaki A, Hatziapostolou M, Iliopoulos D. Drakaki A, et al. Among authors: hatziapostolou m. Curr Pharm Des. 2013;19(7):1180-91. doi: 10.2174/138161213804805658. Curr Pharm Des. 2013. PMID: 23092338 Review.
miRNAs link metabolic reprogramming to oncogenesis.
Hatziapostolou M, Polytarchou C, Iliopoulos D. Hatziapostolou M, et al. Trends Endocrinol Metab. 2013 Jul;24(7):361-73. doi: 10.1016/j.tem.2013.03.002. Epub 2013 Apr 19. Trends Endocrinol Metab. 2013. PMID: 23602813 Review.
Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
Vorvis C, Hatziapostolou M, Mahurkar-Joshi S, Koutsioumpa M, Williams J, Donahue TR, Poultsides GA, Eibl G, Iliopoulos D. Vorvis C, et al. Among authors: hatziapostolou m. Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1124-37. doi: 10.1152/ajpgi.00035.2016. Epub 2016 May 5. Am J Physiol Gastrointest Liver Physiol. 2016. PMID: 27151939 Free PMC article.
46 results